Metabolic markers often improve after two to three months
For Dementia Patients Despite some promise from early clinical trials, a meta-analysis of clinical trials concluded that ALCAR supplements are unlikely to provide a clinically meaningful benefit on the cognitive, behavioral, or functional abilities of Alzheimer's patients [1]
The GLP-1 (glucagon-like peptide-1) medications mimic the hormone that is produced after we eat
Studies demonstrated significant reductions in visceral adipose tissue (VAT) within 6 to 12 weeks of consistent daily administration, with effects maintained for the duration of treatment
No randomized controlled trial has tested sublingual tirzepatide for weight loss, blood sugar control, or any other outcome
Digestive discomfort: Some people experience mild stomach upset, bloating, or cramps, especially when taking large doses at once